News Releases

Omnicell To Present At The 35th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 4, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA. 

Omnicell Speakers: Randall A. Lipps, chairman, president, CEO & founder and Peter Kuipers, executive vice president & CFO

Date: Thursday, January 12, 2017
Time: 10:00 a.m. PT
Location: Westin St. Francis Hotel, San Francisco, CA
Availability: The audio-webcast of the live presentation may be accessed by visiting: http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 90 days on the Omnicell website.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed® solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom.  These pharmacies are served via Omnicell's sales channels and our solutions enable them to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-E

 

SOURCE Omnicell, Inc.

For further information: Peter Kuipers, Omnicell, Inc., 800-850-6664, ext. 6180, peter.kuipers@omnicell.com; or Nigel Smith, Next Step Communications, (781) 326-1741, omnicell@nextstepcomms.com